CDLX News and Press, Cardlytics Inc. From 09/15/25

Cardlytics Inc. (NASDAQ: CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstand...

Industry-leading card-linked offer network recognized amongst 4,000+ global submissions Cardlytics Inc. (NASDAQ: CDLX) today announced that Cardlytics’ card-linked offer (CLO) network has won “Best Digital Ad Network” in the 2025 MarTech Breakthrough Awards pr...

A look at the top 10 most actives in the United States CIMG Inc. (IMG) rose 214.9% to $0.6299 on volume of 353,208,780 shares FOXO Technologies Inc. Class A (FOXO) rose 2.7% to $0.1314 on volume of 139,743,452 shares LQR House Inc. (YHC) rose 18.3% to $1.4195 on volume of 87,637,299 shares ...

2025-08-06 20:21:04 ET More on Cardlytics Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated Cardlytics Q2 2025 Earnings Preview Seeking Alpha’s Quant Rating on Cardlytics ...

2025-08-06 20:20:32 ET Cardlytics, Inc. (CDLX) Q2 2025 Earnings Conference Call August 06, 2025, 5:00 PM ET Company Participants Alexis DeSieno - Chief Financial Officer Amit Gupta - CEO & Director Nick Lynton - Chief Legal & Privacy Officer and Secretary...

2025-08-06 17:43:31 ET More on Cardlytics Cardlytics: Underrecognized Margin Recovery; Strong Buy Reiterated Cardlytics Q2 2025 Earnings Preview Seeking Alpha’s Quant Rating on Cardlytics Historical earnings data for Cardlytics Financial inform...

Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025. "Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our un...

Sera Prognostics Inc. (SERA) is expected to report $-0.21 for Q2 2025 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.51 for Q2 2025 Context Therapeutics Inc. (CNTX) is expected to report $-0.06 for Q2 2025 Genco Shipping & Trading ...

Cardlytics Inc. (CDLX) is expected to report $-0.43 for Q2 2025

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 30, 2025, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 454,600 restricted stock units of Cardlytics to two newly hired employees. The restricted stock units were granted as material inducem...